Table of Content

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Information Sources
Secondary Research
Geographic Breakdown
Segmentation Breakdown

Chapter 2 Summary and Highlights
Market Outlook
Market Summary
Report Highlights

Chapter 3 Market Overview and Definitions
Overview
Diabetes
Type 1 Diabetes
Type 2 Diabetes
Role of Insulin
Diabetes Treatment
Market Dynamics
Market Drivers
Market Restrains
Market Opportunities
Market Challenges

Chapter 4 Market Breakdown by Region
Market Overview and Discussion
Market Size and Forecast
North America
Europe
Asia-Pacific
Rest of the World

Chapter 5 Market Breakdown by Onset Time
Market Overview and Discussion
Long-Acting Insulin
Rapid-Acting Insulin
Intermediate-Acting Insulin
Short-Acting Insulin
Market Size and Forecast
Long-Acting Insulin Pens
Intermediate-Acting Insulin Pens
Short-Acting Insulin Pens
Rapid-Acting Insulin Pens

Chapter 6 Market Breakdown by End User
Market Overview
Hospitals
Pharmacies
Market Size and Forecast
Global Insulin Pen End-Users Market
North American End-User Market
European End-User Market
Asia-Pacific End-User Market
Rest of the World End-User Market

Chapter 7 ESG Development
Introduction
Environmental
Social
Governance
Case Study
Novo Nordisk A/S

Chapter 8 Competitive Landscape
Overview and Industry Scenario
Company Shares
Recent Key Developments

Chapter 9 Company Profiles
ASTRAZENECA
BIOCON
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
ELI LILLY AND CO.
JOHNSON & JOHNSON SERVICES INC.
MERCK & CO. INC.
NOVARTIS AG
NOVO NORDISK A/S
SANOFI
VIATRIS INC.

Chapter 10 Appendix: Acronyms
List of Acronyms



List of Figures


Summary Figure A : Global Market for Insulin Pens, by Type, 2020-2028
Summary Figure B : Global Market Shares of Insulin Pens, by Type, 2022
Figure 1 : Market Dynamics for the Global Insulin Pens Market
Figure 2 : Global Market Shares of Insulin Pens, by Region, 2022
Figure 3 : North American Market Shares of Insulin Pens, by Type, 2022
Figure 4 : European Market Shares of Insulin Pens, by Type, 2022
Figure 5 : Asia-Pacific Market Shares of Insulin Pens, by Type, 2022
Figure 6 : Rest of the World Market Shares of Insulin Pens, by Type, 2022
Figure 7 : Global Market Shares of Insulin Pens, by Onset Time, 2022
Figure 8 : Global Market Shares of Long-Acting Insulin Pens, by Region, 2022
Figure 9 : Global Market Shares of Intermediate-Acting Insulin Pens, by Region, 2022
Figure 10 : Global Market Shares of Short-Acting Insulin Pens, by Region, 2022
Figure 11 : Global Market Shares of Rapid-Acting Insulin Pens, by Region, 2022
Figure 12 : North American Market Shares for Insulin Pens, by End User, 2022
Figure 13 : European Market Shares for Insulin Pens, by End User, 2022
Figure 14 : Asia-Pacific Market Shares for Insulin Pens, by End User, 2022
Figure 15 : Rest of the World Market Shares for Insulin Pens, by End User, 2022
Figure 16 : Global Market Shares of Insulin Pens, by Company, 2022
Figure 17 : Global Market Shares of Insulin Pens, by Product, 2022
Figure 18 : Global Insulin Market, by Product, Sales Revenue, 2022
Figure 19 : AstraZeneca: Revenue Share, by Country, 2022
Figure 20 : Merck & Co. Inc.: Annual Revenue, by Segment, 2020–2022
Figure 21 : Novartis AG: Innovative Medicine, Market Share, by Region, 2022
Figure 22 : Novartis AG: Market Share, by Region, 2022
Figure 23 : Sanofi: Annual Revenue, by Region, 2022
Figure 24 : Sanofi: Revenue, by Segment, 2022
Figure 25 : Viatris Inc.: Sales Share, by Region, 2022

List of Tables


Summary Table : Global Market for Insulin Pens, by Type, Through 2028
Table 1 : Global Insulin Pens Market Drivers
Table 2 : Global Insulin Pens Market Restraints
Table 3 : Global Insulin Pens Market Challenges
Table 4 : Global Market for Insulin Pens, by Region, Through 2028
Table 5 : North American Market for Insulin Pens, by Type, Through 2028
Table 6 : European Market for Insulin Pens, by Type, Through 2028
Table 7 : Asia-Pacific Market for Insulin Pens, by Type, Through 2028
Table 8 : Rest of the World Market for Insulin Pens, by Type, Through 2028
Table 9 : Insulin Type and Features
Table 10 : Leading Insulin Products and Their Types
Table 11 : Global Market for Insulin Pens, by Onset Time, Through 2028
Table 12 : Global Market for Long-Acting Insulin Pens, by Region, Through 2028
Table 13 : Global Market for Intermediate-Acting Insulin Pens, by Region, Through 2028
Table 14 : Global Market for Short- Acting Insulin Pens, by Region, Through 2028
Table 15 : Global Market for Rapid-Acting Insulin Pens, by Region, Through 2028
Table 16 : Global Market for Insulin Pens for Hospitals, by Region, Through 2028
Table 17 : Global Market for Insulin Pens for Pharmacies, by Region, Through 2028
Table 18 : North American Market for Insulin Pens, by End User, Through 2028
Table 19 : European Market for Insulin Pens, by End User, Through 2028
Table 20 : Asia-Pacific Market for Insulin Pens, by End User, Through 2028
Table 21 : Rest of the World Market for Insulin Pens, by End User, Through 2028
Table 22 : Top Pharma Companies’ ESG Risk Ratings
Table 23 : Novo Nordisk A/S: Key Environmental Performance Indicators, 2020–2022
Table 24 : Novo Nordisk A/S: Key Social Performance Indicators, 2020–2022
Table 25 : Novo Nordisk A/S: Key Governance Performance Indicators, 2020-2022
Table 26 : Global Market Share of Insulin Pens, by Company, 2022
Table 27 : Global Market Shares of Insulin Pens, by Product, 2022
Table 28 : Global Insulin Market, Product Sales Revenue, 2020–2022
Table 29 : Global Diabetes Treatment Market, Selected Recent Key Developments, September 2019–August 2022
Table 30 : AstraZeneca: Company Snapshot
Table 31 : AstraZeneca: Diabetology Product Information
Table 32 : AstraZeneca: Revenue, 2020-2022
Table 33 : AstraZeneca: Recent Key Developments, 2021–2023
Table 34 : Biocon: Company Snapshot
Table 35 : Biocon: Diabetology Product Information
Table 36 : Biocon: Revenue, 2020–2022
Table 37 : Biocon: Key Developments, 2021–2023
Table 38 : Boehringer Ingelheim International GmbH: Company Snapshot
Table 39 : Boehringer Ingelheim International GmbH: Diabetology Product Information
Table 40 : Boehringer Ingelheim International GmbH: Annual Revenue, 2020–2022
Table 41 : Boehringer Ingelheim International GmbH: Key Developments, 2019–2021
Table 42 : Eli Lilly and Co.: Company Snapshot
Table 43 : Eli Lilly and Co: Diabetology Product Information
Table 44 : Eli Lilly and Co: Annual Revenue, 2020–2022
Table 45 : Eli Lilly and Co: Recent Key Developments, 2020–2022
Table 46 : Johnson & Johnson Services Inc.: Company Snapshot
Table 47 : Johnson & Johnson Services Inc.: Diabetology Product Information
Table 48 : Johnson & Johnson Services Inc.: Annual Revenue, 2020–2022
Table 49 : Merck & Co. Inc.: Company Snapshot
Table 50 : Merck & Co. Inc.: Diabetology Product Information
Table 51 : Merck & Co. Inc.: Financials, 2020–2022
Table 52 : Merck & Co. Inc.: Key Developments, 2021
Table 53 : Novartis AG: Company Snapshot
Table 54 : Novartis AG: Diabetology Product Information
Table 55 : Novartis AG: Financials, 2020–2022
Table 56 : Novartis AG: Key Developments, 2023
Table 57 : Novo Nordisk A/S: Company Snapshot
Table 58 : Novo Nordisk A/S: Diabetology Product Information
Table 59 : Novo Nordisk A/S: Revenue, 2020–2022
Table 60 : Novo Nordisk A/S: Recent Developments, 2019-2022
Table 61 : Sanofi: Company Snapshot
Table 62 : Sanofi: Business Segment
Table 63 : Sanofi: Diabetology Product Information
Table 64 : Sanofi: Annual Revenue, 2020–2022
Table 65 : Sanofi: Key Developments, 2021–2023
Table 66 : Viatris Inc.: Company Snapshot
Table 67 : Viatris Inc.: Annual Revenue, 2020-2022
Table 68 : Viatris Inc.: Diabetology Product Information
Table 69 : Major Acronyms Used in This Report